UBT251 vs Cotadutide

Head-to-head comparison of UBT251 (UBT251, glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide/glucagon receptor triagonist) and Cotadutide (MEDI0382, long-acting GLP-1 and glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyUBT251Cotadutide
CategoryWeight ManagementWeight Management
Full NameUBT251, glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide/glucagon receptor triagonistMEDI0382, long-acting GLP-1 and glucagon receptor dual agonist
Molecular WeightN/A~4,700 Da
Half-LifeApproximately 1 weekApproximately 24 hours
Amino AcidsN/A37
Typical DoseInvestigational; no established human dose0.3-3 mg daily in clinical studies
RouteSubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count818
Research StatusPre-clinicalClinical

UBT251 Benefits

  • weight reduction
  • improved satiety
  • enhanced energy expenditure
  • better insulin sensitivity

Cotadutide Benefits

  • body-weight reduction
  • improved insulin sensitivity
  • reduced hepatic fat
  • appetite suppression

UBT251 Dosing

once-weekly subcutaneous injection|dose escalation in studies|maintenance after tolerability assessment

Cotadutide Dosing

Once-daily SC in trials|Start low and titrate based on tolerance|Monitor GI adverse effects

UBT251 Side Effects

  • nausea
  • diarrhea
  • fatigue

Cotadutide Side Effects

  • nausea
  • vomiting
  • diarrhea

Research Overview

UBT251

Published work supports strong anti-obesity activity in preclinical models, with translation into human studies still emerging. The compound remains investigational and is best characterized as an early multi-agonist program.

Cotadutide

Phase 2 studies reported dose-dependent weight loss and favorable changes in glycemic and liver-related markers. It is one of the most cited synthetic dual-agonist peptides for obesity research.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

UBT251 stacks with:

metforminorlistat

Cotadutide stacks with:

dietary-calorie-restrictionexercise-program
glp1gipglucagontriagonistweight-managementGLP-1glucagon-coagonistdual-agonistobesity-research